Clinical Trial Detail

NCT ID	NCT03367819
Title	Isatuximab in Combination With REGN2810 in Patients With Advanced Malignancies
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	no
Sponsors	Sanofi
Indications	lung non-small cell carcinoma prostate cancer
Therapies	Isatuximab Cemiplimab + Isatuximab
Age Groups:	adult senior